Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been newly diagnosed with ovarian cancer and have not yet received any treatment, and you are a candidate for surgery or chemotherapy given before surgery.
- You have been newly diagnosed with triple-negative breast cancer and have not yet received any treatment, and you are a candidate for surgery or chemotherapy given before surgery.
- You have been newly diagnosed with head and neck cancer and have not yet received any treatment, and you are a candidate for surgery.
- You have been newly diagnosed with vulva cancer (any type) or cervical cancer at certain stages and have not yet received any treatment (confirm with trial site for specific stage details).
- You have been newly diagnosed with a type of sarcoma — specifically breast angiosarcoma or uterine sarcoma — and have not yet received any treatment, and you are a candidate for surgery or other systemic treatment.
- You are 18 years of age or older.
- You are willing and able to sign a consent form agreeing to take part in the trial.
Who may not be able to join:
- You are under 18 years of age.
- You have personal, family, social, or location-related circumstances that might make it difficult to follow the trial's schedule and requirements (confirm with trial site).
- You are currently under legal guardianship or have had your personal freedoms restricted by a legal authority.
- You are not registered with the French Social Security system (this trial appears to require French social security affiliation — confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Edith BORCOMAN, Prof., Institut Curie
Phone: 01 47 11 23 78
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation between tumor molecular/immunological profile and Baseline clinicobiological features
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.